Research summary
Probiotics and Immune Health
Quick answer
Meta-analyses of randomized placebo-controlled trials suggest orally ingested probiotics may modestly reduce the risk, duration, and severity of respiratory tract infections in nonelderly adults, but effect sizes are small, results vary by population, and the optimal regimen is not established.[1], [2]
Limitations of the evidence
The pooled effects on respiratory tract infections are small, and the benefit seen in general adult populations was not reproduced in physically active groups, indicating the response varies by population and likely by the specific product and delivery format used.[1]
Because most underlying trials carried some risk of bias and used differing strains and doses, and because the optimal regimen is undefined, these results should not be treated as a guarantee of protection or as medical advice.[1], [2]
What does the evidence support?
Read each finding with its qualification. These are source-supported statements, not a ranking of products or personal treatment advice.
| Finding and qualification | References |
|---|---|
| In a meta-analysis of randomized placebo-controlled trials in nonelderly adults, orally ingested probiotics taken for at least one week modestly lowered the risk of experiencing at least one respiratory tract infection compared with placebo. Based on randomized trials in adults aged 18-65 using orally ingested probiotics for at least 1 week; the reduction was modest (relative risk 0.91) and most included studies carried some risk of bias. The studied dose was Any dose of orally ingested probiotic for at least 1 week (doses varied across included trials). | [1] |
| Across the same meta-analysis, probiotics were associated with modest reductions in the duration and severity of respiratory tract infections relative to placebo, though benefits were not seen in physically active populations. Effect sizes were small (Hedges' g around -0.23 for duration and -0.16 for severity) using orally ingested probiotics for at least 1 week; no benefit was observed in physically active populations. The studied dose was Any dose of orally ingested probiotic for at least 1 week (doses varied across included trials). | [1] |
| Evidence for probiotics and immune health remains limited and the optimal dose, composition, timing, and duration of supplementation have not been established. Drawn from meta-analyses whose authors rated most included studies as having some risk-of-bias concerns and called for larger trials; findings vary by population and delivery format. | [1], [2] |
What the trials measured
The most directly relevant evidence comes from a systematic review and meta-analysis of 42 randomized, placebo-controlled studies in adults aged 18 to 65 (about 9,000 participants combined). In that pooled analysis, people taking orally ingested probiotics for at least one week had a modestly lower risk of experiencing at least one respiratory tract infection than those taking placebo.[1]
The same analysis also reported small reductions in how long respiratory tract infections lasted and how severe they were, again compared with placebo. Notably, these benefits were not observed in physically active populations, which suggests the effect is not uniform across all groups.[1]
Athletes and immune markers
A separate meta-analysis of randomized controlled trials in elite athletes adds nuance. It did not find a change in the number or duration of upper respiratory tract infection episodes, but it did report a reduction in the total symptom severity score and lower levels of certain inflammatory markers after probiotic supplementation. This mixed picture reinforces that any immune-related effect appears modest and context-dependent.[1], [2]
How to weigh the evidence
Across these meta-analyses, the authors rated most included studies as having some risk-of-bias concerns and called for larger trials. The optimal dose, strain composition, timing, and duration of probiotic supplementation for immune support have not been established, so current findings are best read as promising but limited rather than definitive.[1], [2]
References
- Orally Ingested Probiotics, Prebiotics, and Synbiotics as Countermeasures for Respiratory Tract Infections in Nonelderly Adults: A Systematic Review and Meta-Analysis.. Advances in nutrition (Bethesda, Md.). 2022. Systematic review and meta-analysis View source →
- Probiotic Supplementation and Respiratory Infection and Immune Function in Athletes: Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Journal of athletic training. 2021. Systematic review and meta-analysis View source →
Frequently asked questions
What probiotic benefits are supported beyond digestion?
Beyond digestive uses, randomized-trial meta-analyses report modest or preliminary signals for respiratory infections in adults, anxiety scores, atopic-dermatitis prevention when probiotics were given during pregnancy and continued in infancy, and short-term body-weight change in adults with overweight or obesity. Effects are not uniform, depressive symptoms did not improve significantly, and no single probiotic supports every outcome.
Sources: Orally Ingested Probiotics, Prebiotics, and Synbiotics as Countermeasures for Respiratory Tract Infections in Nonelderly Adults: A Systematic Review and Meta-Analysis.; Effectiveness of probiotic/prebiotic/synbiotic treatments on anxiety: A systematic review and meta-analysis of randomized controlled trials.; Effect of probiotic supplementation on cognition and depressive symptoms in patients with depression: A systematic review and meta-analysis.; Probiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studies.; Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials.; Effects of oral supplementation of probiotics on body weight and visceral fat in obese patients: a meta-analysis and systematic review.
Read the full FAQ and limitations →